What does Centre d'Imagerie Médicale de Gembloux do?

Centre d'Imagerie Médicale de Gembloux is a healthcare practice in Gembloux. Private Limited, started on 6 September 2022, 1 establishment.

What is the address of Centre d'Imagerie Médicale de Gembloux?

The registered office of Centre d'Imagerie Médicale de Gembloux is located at Chaussée de Tirlemont 34 D, 5030 Gembloux.

Is Centre d'Imagerie Médicale de Gembloux still active?

Yes. According to the CBE (29 October 2026) Centre d'Imagerie Médicale de Gembloux is active, legal situation “Normale toestand”, started on 6 September 2022.

Is Centre d'Imagerie Médicale de Gembloux registered on Peppol?

Yes, Centre d'Imagerie Médicale de Gembloux is registered on the Peppol network with ID 0208:0790491996.

What is the enterprise number of Centre d'Imagerie Médicale de Gembloux?

The enterprise number of Centre d'Imagerie Médicale de Gembloux is BE0790491996.

When was Centre d'Imagerie Médicale de Gembloux founded?

Centre d'Imagerie Médicale de Gembloux was founded on 6 September 2022.

Who are the directors of Centre d'Imagerie Médicale de Gembloux?

According to the 2025 annual accounts, the directors of Centre d'Imagerie Médicale de Gembloux are: RADIOLOGY PARTNERS EUROPE SRL, BAUDREZ RX SRL, DEWAEL RX SRL, SL Radiologie SRL, CARDINAEL IMAGERIE MEDICALE SRL, Docteur Sébastien de Wulf Radiologie SRL, SIMEDIC SRL, VAES-VIERIN MEDIC SRL.

Is Centre d'Imagerie Médicale de Gembloux a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 6 September 2022; 3 annual accounts filed, latest fiscal year 2025; 9 directors known from the annual account.

How much profit did Centre d'Imagerie Médicale de Gembloux make in 2025?

Centre d'Imagerie Médicale de Gembloux posted a profit after taxes of € 804,845 in financial year 2025.

What is the revenue of Centre d'Imagerie Médicale de Gembloux?

As a small company, Centre d'Imagerie Médicale de Gembloux is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 1,137,687.

How much does an employee at Centre d'Imagerie Médicale de Gembloux earn?

The average wage cost per full-time employee at Centre d'Imagerie Médicale de Gembloux was € 66,100 in 2025: staff costs of € 330,653 for 5 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does Centre d'Imagerie Médicale de Gembloux have?

According to the 2025 annual accounts, Centre d'Imagerie Médicale de Gembloux has 5 full-time equivalents (FTE).

Centre d'Imagerie Médicale de Gembloux (Private Limited)

Dossier Centre d'Imagerie Médicale de Gembloux, printed on 29 October 2026 from databakkes.be/en/0790491996/centre-d-imagerie-medicale-de-gembloux. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 47 % of short-term debt in 2025; threshold 65 %.
Board fully replaced NBB

No director from three years ago is still active according to annual account 2025.

Financials

Financial year 2025

Centre d'Imagerie Médicale de Gembloux from Gembloux, company number BE0790491996, closed financial year 2025 with a result of € 804,845 after tax. For that financial year Centre d'Imagerie Médicale de Gembloux recorded a gross margin of € 1.1 million and equity of € 1 million. Compared with financial year 2024, the result moved from € 163,380 to € 804,845. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 23, 2026.

What it is worth Growing

€ 1 million

▲ € 804,845 vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 804,845

▲ € 641,465 vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 51,649

▲ 8% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 969,039.

People and assets in 2025

Full-time equivalents

▲ 0.5 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 330,653

▲ 33% vs 2024

€ 66,100 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 523,321

▼ 15% vs 2024

Of which on lease € 474,789.

Debts at end 2025

Bank debt ≈ 5 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 1.6 million

▼ 28% vs 2024

€ 321,622 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.

Owed to suppliers

€ 39,997

▲ 2% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 89,544

▼ 11% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 659,384 Gross margin 2023: € 659,384 First fiscal year in the series	€ 717,275 Gross margin 2024: € 717,275 ▲ 9% vs 2023 (€ 659,384) Favourable step	€ 1,137,687 Gross margin 2025: € 1,137,687 ▲ 59% vs 2024 (€ 717,275) Favourable step	▲ 59%
Profit after taxes	€ 324,914 Profit after taxes 2023: € 324,914 First fiscal year in the series	€ 163,380 Profit after taxes 2024: € 163,380 ▼ 50% vs 2023 (€ 324,914) Unfavourable step	€ 804,845 Profit after taxes 2025: € 804,845 ▲ € 641,465 vs 2024 (€ 163,380) Favourable step	▲ € 641,465
Equity	€ 70,814 Equity 2023: € 70,814 First fiscal year in the series	€ 234,194 Equity 2024: € 234,194 ▲ 231% vs 2023 (€ 70,814) Favourable step	€ 1,039,039 Equity 2025: € 1,039,039 ▲ € 804,845 vs 2024 (€ 234,194) Favourable step	▲ € 804,845
Total debts	€ 1,749,960 Total debts 2023: € 1,749,960 First fiscal year in the series	€ 2,720,384 Total debts 2024: € 2,720,384 ▲ 55% vs 2023 (€ 1,749,960) Unfavourable step	€ 1,789,249 Total debts 2025: € 1,789,249 ▼ 34% vs 2024 (€ 2,720,384) Favourable step	▼ 34%
Cash	€ 410,100 Cash 2023: € 410,100 First fiscal year in the series	€ 47,980 Cash 2024: € 47,980 ▼ 88% vs 2023 (€ 410,100) Unfavourable step	€ 51,649 Cash 2025: € 51,649 ▲ 8% vs 2024 (€ 47,980) Favourable step	▲ 8%
Retained profit	€ 814 Retained profit 2023: € 814 First fiscal year in the series	€ 164,194 Retained profit 2024: € 164,194 ▲ € 163,380 vs 2023 (€ 814) Favourable step	€ 969,039 Retained profit 2025: € 969,039 ▲ € 804,845 vs 2024 (€ 164,194) Favourable step	▲ € 804,845
Dividend	€ 324,100 Dividend 2023: € 324,100 First fiscal year in the series	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 324,100) Unchanged	€ 0 Dividend 2025: € 0 Unchanged (€ 0) Unchanged
Bank debt	€ 1,162,299 Bank debt 2023: € 1,162,299 First fiscal year in the series	€ 2,240,813 Bank debt 2024: € 2,240,813 ▲ 93% vs 2023 (€ 1,162,299) Unfavourable step	€ 1,623,995 Bank debt 2025: € 1,623,995 ▼ 28% vs 2024 (€ 2,240,813) Favourable step	▼ 28%
Balance sheet total	€ 1,820,773 Balance sheet total 2023: € 1,820,773 First fiscal year in the series	€ 2,954,578 Balance sheet total 2024: € 2,954,578 ▲ 62% vs 2023 (€ 1,820,773) Unchanged	€ 2,828,288 Balance sheet total 2025: € 2,828,288 ▼ 4% vs 2024 (€ 2,954,578) Unchanged	▼ 4%
Employees (FTE)	3.3 Employees (FTE) 2023: 3.3 First fiscal year in the series	4.5 Employees (FTE) 2024: 4.5 ▲ 1.2 vs 2023 (3.3) Unchanged	5 Employees (FTE) 2025: 5 ▲ 0.5 vs 2024 (4.5) Unchanged	▲ 0.5

Key figures of Centre d'Imagerie Médicale de Gembloux, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Centre d'Imagerie Médicale de Gembloux?

What happened at Centre d'Imagerie Médicale de Gembloux in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 23, 2026 New annual accounts for financial year 2025: profit of € 804,845 (▲ € 641,465 vs 2024). Source: NBB ↗
2026 RADIOLOGY PARTNERS EUROPE SRL became a director. NBB
2026 BAUDREZ RX SRL stepped down as director. NBB
2026 DEWAEL RX SRL stepped down as director. NBB
2026 SL Radiologie SRL stepped down as director. NBB
2026 CARDINAEL IMAGERIE MEDICALE SRL stepped down as director. NBB
2026 Docteur Sébastien de Wulf Radiologie SRL stepped down as director. NBB
2026 SIMEDIC SRL stepped down as director. NBB

In short

From € 324,914 profit in 2023 to € 804,845 profit in 2025.

Paid € 250,944 in corporate taxes since 2023.

Best year ever: 2025, with € 804,845 profit.

On average € 227,500 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

CARDINAEL IMAGERIE MEDICALE 12.5%

Docteur Guillaume VERLYNDE 12.5%

DEWAEL RX 12.5%

SL Radiologie 12.5%

The stake of CARDINAEL IMAGERIE MEDICALE, Docteur Guillaume VERLYNDE, DEWAEL RX, SL Radiologie comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

Centre d'Imagerie Médicale de Gembloux

Centre RX de Wavre 100%

Immo X

Behind Centre d'Imagerie Médicale de Gembloux is RADIOLOGY PARTNERS EUROPE SRL. The shares are held by CARDINAEL IMAGERIE MEDICALE (12.5%), Docteur Guillaume VERLYNDE (12.5%), DEWAEL RX (12.5%) and SL Radiologie (12.5%). It owns 100% of Centre RX de Wavre and Immo X itself.